$ONC
BeiGene, Ltd. Stock $onc

$onc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000165130822000071 Filed on May 09, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$306.6M	$1.362B	$605.9M
YoY Change	-49.39%	1261.08%	1063.82%
Cost Of Revenue	$65.24M	$329.3M	$32.69M
YoY Change	99.59%	116.72%	131.01%
Gross Profit	$241.4M	$1.033B	$573.2M
YoY Change	-57.89%	102.73%	1411.97%
Gross Profit Margin	78.72%	75.83%	94.61%
Selling, General & Admin	$294.6M	$2.194B	$182.1M
YoY Change	61.76%	60.31%	70.06%
% of Gross Profit	122.03%	212.34%	31.77%
Research & Development	$389.9M	$2.825B	$320.7M
YoY Change	21.57%	29.75%	5.4%
% of Gross Profit	161.53%	273.45%	55.95%
Depreciation & Amortization	$16.60M	$192.8M	$9.632M
YoY Change	72.34%	8.31%	24.28%
% of Gross Profit	6.88%	18.66%	1.68%
Operating Expenses	$684.5M	$5.177B	$502.8M
YoY Change	36.13%	39.34%	22.23%
Operating Profit	-$443.3M	-$4.144B	$70.17M
YoY Change	-731.76%	754.65%	-118.77%
Interest Expense	$21.68M	-$119.1M	-$68.00M
YoY Change	-131.89%	-1693.08%
% of Operating Profit			-96.91%
Other Income/Expense, Net	$11.97M	$287.0K	-$4.123M
YoY Change	-390.25%	-265.9%	-212.01%
Pretax Income	-$421.2M	-$4.263B	$61.87M
YoY Change	-780.92%	33.29%	-117.02%
Income Tax	$13.03M	-$16.17M	-$4.630M
% Of Pretax Income			-7.48%
Net Earnings	-$434.3M	-$4.247B	$66.50M
YoY Change	-753.09%	798.44%	-118.28%
Net Earnings / Revenue	-141.63%	-311.74%	10.98%
Basic Earnings Per Share	-$0.33		$0.06
Diluted Earnings Per Share	-$0.33	-$3.182M	$0.05
COMMON SHARES
Basic Shares Outstanding	1.332B shares	1.220B shares	1.189B shares
Diluted Shares Outstanding	1.332B shares		1.257B shares

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.245B	$6.618B	$4.812B
YoY Change	29.77%	42.29%	42.62%
Cash & Equivalents	$4.347B	$4.376B	$1.902B
Short-Term Investments	$1.898B	$2.242B	$2.910B
Other Short-Term Assets	$14.01B	$27.06M
YoY Change		131.96%
Inventory	$245.6M	$242.6M	$72.97M
Prepaid Expenses
Receivables	$190.8M	$483.1M	$84.01M
Other Receivables	$117.0M	$12.01M	$2.974M
Total Short-Term Assets	$6.948B	$7.614B	$5.141B
YoY Change	35.15%	53.48%	43.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$624.7M	$587.6M	$373.9M
YoY Change	67.05%	64.28%	55.6%
Goodwill	$109.0K	$109.0K	$109.0K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$22.44M	$22.96M
YoY Change
Other Assets	$164.6M	$163.0M	$127.8M
YoY Change	28.74%	44.18%	35.62%
Total Long-Term Assets	$1.073B	$1.032B	$680.0M
YoY Change	57.82%	61.24%	44.07%
TOTAL ASSETS
Total Short-Term Assets	$6.948B	$7.614B	$5.141B
Total Long-Term Assets	$1.073B	$1.032B	$680.0M
Total Assets	$8.021B	$8.646B	$5.821B
YoY Change	37.8%	54.37%	43.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$236.9M	$262.4M	$146.9M
YoY Change	61.25%	13.12%	49.37%
Accrued Expenses	$386.0M	$558.1M	$312.1M
YoY Change	23.66%	61.22%	74.05%
Deferred Revenue	$163.7M	$187.4M	$71.65M
YoY Change	128.41%
Short-Term Debt	$2.473B	$2.622B
YoY Change		682.62%
Long-Term Debt Due	2.582B CNies	2.725B cnies	2.654B CNies
YoY Change	-2.69%	24.65%	23388.84%
Total Short-Term Liabilities	$1.376B	$1.600B	$1.113B
YoY Change	23.71%	48.77%	146.25%
LONG-TERM LIABILITIES
Long-Term Debt	1.278B CNies	1.288B cnies	1.265B CNies
YoY Change	1.06%	7.49%	1443.85%
Other Long-Term Liabilities	$51.83M	$54.23M	$55.32M
YoY Change	-6.31%	-5.56%	22.11%
Total Long-Term Liabilities	$759.6M	$803.4M	$704.9M
YoY Change	7.76%	22.41%	-10.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.376B	$1.600B	$1.113B
Total Long-Term Liabilities	$759.6M	$803.4M	$704.9M
Total Liabilities	$2.136B	$2.403B	$1.817B
YoY Change	17.52%	38.78%	46.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.400B	-$4.966B	-$3.486B
YoY Change	54.9%	39.78%	50.3%
Common Stock	$133.0K	$133.0K	$119.0K
YoY Change	11.76%	12.71%	17.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.886B	$6.243B	$4.004B
YoY Change
Total Liabilities & Shareholders Equity	$8.021B	$8.646B	$5.821B
YoY Change	37.8%	54.37%	43.12%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$434.3M	-$4.247B	$66.50M
YoY Change	-753.09%	798.44%	-118.28%
Depreciation, Depletion And Amortization	$16.60M	$192.8M	$9.632M
YoY Change	72.34%	8.31%	24.28%
Cash From Operating Activities	-$236.6M	-$3.109B	$125.1M
YoY Change	-289.11%	28.25%	-136.58%
INVESTING ACTIVITIES
Capital Expenditures	$45.13M	-$1.240B	$42.39M
YoY Change	6.47%	315.92%	96.86%
Acquisitions
YoY Change
Other Investing Activities	$2.075B	$231.6M	$1.419B
YoY Change	46.21%	-52.51%
Cash From Investing Activities	$210.4M	-$1.009B	$291.9M
YoY Change	-27.93%	-632.43%	-126.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net	$0.00
YoY Change
Cash From Financing Activities	-$11.27M	21.46B	$107.4M
YoY Change	-110.49%	899.43%	-96.17%
NET CHANGE
Cash From Operating Activities	-$236.6M	-3.109B	$125.1M
Cash From Investing Activities	$210.4M	-1.009B	$291.9M
Cash From Financing Activities	-$11.27M	21.46B	$107.4M
Net Change In Cash	-$28.44M	17.34B	$520.4M
YoY Change	-105.46%	-19856.64%	-61.14%
FREE CASH FLOW
Cash From Operating Activities	-$236.6M	-$3.109B	$125.1M
Capital Expenditures	$45.13M	-$1.240B	$42.39M
Free Cash Flow	-$281.7M	-$1.869B	$82.71M
YoY Change	-440.6%	-12.09%	-122.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001651308
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-37686
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	BEIGENE, LTD.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4347162000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4375678000	USD
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1209416
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Mourant Governance Services (Cayman) Limited
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	94 Solaris Avenue, Camana Bay
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Grand Cayman
CY2022Q1	dei	Entity Address Country EntityAddressCountry	KY
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	KY1-1108
CY2022Q1	dei	City Area Code CityAreaCode	345
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	949-4123
CY2022Q1	dei	Security12b Title Security12bTitle	American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
CY2022Q1	dei	Trading Symbol TradingSymbol	BGNE
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1341305269	shares
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	266436000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	270173000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	115497000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	330000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	328000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1897783000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2241962000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	190800000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	483113000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	245628000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	242626000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	6948139000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7613880000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6958000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6881000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624673000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587605000	USD
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	110424000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	164554000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	385976000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	558055000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	117431000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45807000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46679000	USD
CY2022Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	115760000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	163049000	USD
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1073249000	USD
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1032069000	USD
CY2022Q1	us-gaap	Assets Assets	8021388000	USD
CY2021Q4	us-gaap	Assets Assets	8645949000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	236915000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	262400000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	163658000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1376306000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	187414000	USD
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	38505000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	21395000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22894000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	21925000	USD
CY2022Q1	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	120971000	USD
CY2021Q4	bgne	Research And Development Cost Share Liability Current Portion ResearchAndDevelopmentCostShareLiabilityCurrentPortion	120801000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	407387000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427565000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1599555000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	201605000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	202113000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	204369000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	220289000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39989000	USD
CY2022Q1	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	247572000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43041000	USD
CY2021Q4	bgne	Research And Development Cost Share Liability Noncurrent Portion ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion	269561000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	306626000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	51828000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14219000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	14169000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54234000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	759582000	USD
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	803407000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2135888000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2402962000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	9500000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1334805269	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1334805269	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1334804281	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1334804281	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	133000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	133000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11268290000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11191007000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17454000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	17950000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5400377000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4966103000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5885500000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6242987000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8021388000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8645949000	USD
CY2021Q1	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	188000	USD
CY2021Q1	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	0.73
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	605872000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	65237000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	32685000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	389915000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	320726000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	294573000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	182106000	USD
CY2022Q1	bgne	Amortization Of Intangible Assets Included In Operating Expenses AmortizationOfIntangibleAssetsIncludedInOperatingExpenses	188000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	749913000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	535705000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-443287000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	70167000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10071000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-4179000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11967000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4123000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-421249000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	61865000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13025000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4630000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-434274000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1332017262	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1188943726	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1332017262	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1257489671	shares
CY2022Q1	bgne	Earnings Per American Depository Share Basic EarningsPerAmericanDepositoryShareBasic	-4.24
CY2022Q1	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	-4.24
CY2021Q1	bgne	Earnings Per American Depository Share Per Share EarningsPerAmericanDepositorySharePerShare	0.69
CY2022Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	102462866	shares
CY2021Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Basic WeightedAverageNumberOfAmericanDepositorySharesOutstandingBasic	91457210	shares
CY2022Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	102462866	shares
CY2021Q1	bgne	Weighted Average Number Of American Depository Shares Outstanding Diluted WeightedAverageNumberOfAmericanDepositorySharesOutstandingDiluted	96729975	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-434274000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	9374000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3762000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-497000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-9870000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-473000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-434770000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62757000	USD
CY2022Q1	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-21819000	USD
CY2021Q1	bgne	Amortization Of Research And Development Financing Liability AmortizationOfResearchAndDevelopmentFinancingLiability	-26930000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-434274000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16600000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9632000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	65555000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45833000	USD
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-16974000	USD
CY2021Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3327000	USD
CY2022Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	USD
CY2021Q1	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	8500000	USD
CY2022Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5286000	USD
CY2021Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-12251000	USD
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3544000	USD
CY2021Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	5263000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	150245000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11880000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-292554000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	23656000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3002000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16319000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16953000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	17948000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-35024000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-73178000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-74042000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-26861000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-39676000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1714000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	305000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-236563000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	125095000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45131000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42389000	USD
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	504000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	764163000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	331028000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1107000000	USD
CY2022Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	75000000	USD
CY2021Q1	bgne	Payments To Purchase In Process Research And Development PaymentsToPurchaseInProcessResearchAndDevelopment	8500000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	210393000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	291948000	USD
CY2022Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2021Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10664000	USD
CY2022Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	50000000	USD
CY2021Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	71001000	USD
CY2022Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	73147000	USD
CY2021Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	8282000	USD
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	736000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	25754000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11267000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	107419000	USD
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9000000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4061000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-28437000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	520401000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4382887000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1390005000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4354450000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1910406000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4347162000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1901819000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	330000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	305000	USD
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6958000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-496000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-434274000	USD
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	478000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	6617000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	6927000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	62736000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	30906000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	6242987000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	152000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	11880000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	65555000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	5885500000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	3869243000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	25754000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45833000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3738000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	4003587000	USD
CY2022Q1	bgne	Number Of Persons NumberOfPersons	2300	people
CY2022Q1	bgne	Product Candidate ProductCandidate	3	product
CY2022Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	8300	employee
CY2022Q1	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	28	country
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and determining the standalone selling price of each performance obligation in the Company’s revenue arrangements, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, valuation of inventory, estimating the allowance for credit losses, determining defined benefit pension plan obligations, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities and reported amounts of revenues and expenses. Actual results could differ from these estimates.</span></div>
CY2022Q1	bgne	Number Of Products Initiated Marketing And Promotion NumberOfProductsInitiatedMarketingAndPromotion	5	product
CY2022Q1	bgne	Reimbursement Expense ReimbursementExpense	11711000	USD
CY2021Q1	bgne	Reimbursement Expense ReimbursementExpense	6248000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	7288000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	7209000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1911353000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	188000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	13570000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	1897783000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2245662000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3700000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	2241962000	USD
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	44091000	USD
CY2021Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	43722000	USD
CY2022Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	366000	USD
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments	22437000	USD
CY2021Q4	us-gaap	Equity Method Investments EquityMethodInvestments	22955000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	525048000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	94464000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	78140000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	21972000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9397000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	129192000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	155089000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	245628000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	242626000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	608523000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	137509000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	124286000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	624673000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587605000	USD
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	153659000	USD
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	186843000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	15580000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	9444000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51859000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6052000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45807000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51710000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5031000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46679000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1020000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3055000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4074000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4074000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4074000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4074000	USD
CY2022Q1	bgne	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	26456000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45807000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13025000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4630000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10814000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	889000	USD
CY2022Q1	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	83874000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	415000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	112000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-241000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	48000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2022Q1	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	19000	USD
CY2021Q1	bgne	Accounts Receivable Allowance For Credit Loss Exchange Rate Changes AccountsReceivableAllowanceForCreditLossExchangeRateChanges	1000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	193000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	161000	USD
CY2021Q4	bgne	Prepaid Research And Development Costs PrepaidResearchAndDevelopmentCosts	87239000	USD
CY2022Q1	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	76388000	USD
CY2021Q4	bgne	Prepaid Manufacturing Costs PrepaidManufacturingCosts	78538000	USD
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	52725000	USD
CY2021Q4	us-gaap	Prepaid Taxes PrepaidTaxes	58579000	USD
CY2022Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	20249000	USD
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	12010000	USD
CY2022Q1	us-gaap	Interest Receivable Current InterestReceivableCurrent	5299000	USD
CY2021Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	5052000	USD
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	1906000	USD
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1695000	USD
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	25995000	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	27060000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	266436000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	270173000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	163049000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	109000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	109000	USD
CY2022Q1	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	17784000	USD
CY2021Q4	bgne	Prepayment Of Long Term Asset PrepaymentOfLongTermAsset	14140000	USD
CY2022Q1	bgne	Prepaid Construction Cost PrepaidConstructionCost	24839000	USD
CY2021Q4	bgne	Prepaid Construction Cost PrepaidConstructionCost	24237000	USD
CY2022Q1	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	30967000	USD
CY2021Q4	us-gaap	Value Added Tax Receivable Noncurrent ValueAddedTaxReceivableNoncurrent	17162000	USD
CY2022Q1	bgne	Rental Deposits And Other RentalDepositsAndOther	6965000	USD
CY2021Q4	bgne	Rental Deposits And Other RentalDepositsAndOther	6609000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	83890000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	100792000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	164554000	USD
CY2021Q4	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	71560000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	21328000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	70112000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	139966000	USD
CY2022Q1	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	112825000	USD
CY2021Q4	bgne	Accrued Liabilities External Research And Development AccruedLiabilitiesExternalResearchAndDevelopment	213922000	USD
CY2022Q1	bgne	Accrued Expenses Commercial Activities AccruedExpensesCommercialActivities	79366000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	45661000	USD
CY2022Q1	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	74500000	USD
CY2021Q4	bgne	Accrued Sales Rebates And Returns Current AccruedSalesRebatesAndReturnsCurrent	59639000	USD
CY2022Q1	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	27845000	USD
CY2021Q4	bgne	Accrued Professional Fees And Other Current AccruedProfessionalFeesAndOtherCurrent	27307000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	385976000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	558055000	USD
CY2022Q1	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	43988000	USD
CY2021Q4	bgne	Government Grants Or Incentives Received And Deferred Noncurrent GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent	46352000	USD
CY2022Q1	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7759000	USD
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Noncurrent DefinedBenefitPensionPlanLiabilitiesNoncurrent	7814000	USD
CY2022Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	81000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	68000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	51828000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	54234000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	407387000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2582483000	CNY
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	427565000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2724732000	CNY
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	201605000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1278000000	CNY
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	202113000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1288000000	CNY
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	5528000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6950000	USD
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1281000	USD
CY2021Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	104000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-434274000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	66495000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1332017262	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1188943726	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	68545945	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1332017262	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1257489671	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	65555000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45833000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-496000	USD
CY2022Q1	us-gaap	Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax	0	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-496000	USD
CY2022Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2022Q1	bgne	Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital	0.50
CY2022Q1	bgne	Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage	0.10
CY2022Q1	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	122485000	USD
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	306626000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	605872000	USD

Files In Submission

Name	View Source	Status
0001651308-22-000071-index-headers.html	Edgar Link	pending
0001651308-22-000071-index.html	Edgar Link	pending
0001651308-22-000071.txt	Edgar Link	pending
0001651308-22-000071-xbrl.zip	Edgar Link	pending
bgne-20220331.htm	Edgar Link	pending
bgne-20220331.xsd	Edgar Link	pending
bgne-20220331_cal.xml	Edgar Link	unprocessable
bgne-20220331_def.xml	Edgar Link	unprocessable
bgne-20220331_g1.jpg	Edgar Link	pending
bgne-20220331_htm.xml	Edgar Link	completed
bgne-20220331_lab.xml	Edgar Link	unprocessable
bgne-20220331_pre.xml	Edgar Link	unprocessable
exhibit101-janehuangconsul.htm	Edgar Link	pending
exhibit311-2022q1.htm	Edgar Link	pending
exhibit312-2022q1.htm	Edgar Link	pending
exhibit321-2022q1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ONC
BeiGene, Ltd. Stock $onc

2022 Q1 Form 10-Q Financial Statement

#000165130822000071 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC BeiGene, Ltd. Stock $onc

2022 Q1 Form 10-Q Financial Statement

#000165130822000071 Filed on May 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ONC
BeiGene, Ltd. Stock $onc